Business Context and Reporting Period
This Form 6-K filing by AMBEV S.A. covers the month of December 2021, specifically reporting on a capital increase approved by the Board of Directors on December 22, 2021. The filing details the issuance of new common shares resulting from the exercise of stock options granted in 2011 under the company's Stock Option Plan and Migration Program.
Key Financial Metrics
The filing focuses on capital structure changes rather than operational financial performance. Key metrics include:
- Total Capital Increase: R$ 26,692,974.72
- Total New Shares Issued: 2,229,617 common shares (no par value)
- Issuance Price: R$ 11.97200 per share
- Total Capital Stock Post-Issuance: R$ 58,042,463,613.60
- Aggregate Dilution: 0.005414% relative to issued shares; 0.017584% relative to capital stock
Note: The filing text does not provide values for revenue, profit, cash flow, operating margins, debt levels, or liquidity ratios.
Material Changes
The primary material change is the expansion of the company's authorized capital through the issuance of 2,229,617 new shares. This transaction increased the total capital stock from approximately R$ 58.015 billion to R$ 58.042 billion. The dilution impact on existing shareholders is minimal, totaling less than 0.02% of the capital stock.
Outlook, Risks, and Market Data
The filing does not contain management commentary, forward-looking guidance, or specific risk factors related to operations. However, it provides historical market price data for the company's shares (adjusted for dividends and interest on equity):
- 90-Day Average Price (as of filing): R$ 16.17
- 2021 Q3 Performance: Low of R$ 15.29, High of R$ 18.17, Average of R$ 15.32
- 2020 Full Year Performance: Low of R$ 10.36, High of R$ 19.58, Average of R$ 15.66
Investor Verification Checklist
- Verify the total number of shares outstanding post-issuance (2,229,617 new shares added).
- Confirm the issuance price of R$ 11.97200 against the prevailing market price at the time of exercise.
- Review the full Stock Option Plan details approved in 2013 to understand the scope of remaining options.
- Check subsequent filings for the impact of this capital increase on earnings per share (EPS) and diluted share count.